You are here
- Home
- Drug Products
- All Drug Products
Assessment of the Safety, Tolerability and Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules.
- Disease
- cancer
- Generic Name
- AZD5363
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D3610C00001
- Study Id
- D3610C00001
- ClinicalTrials.gov ID
- NCT01226316
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
